Exact Mass: 527.2339648000001
Exact Mass Matches: 527.2339648000001
Found 146 metabolites which its exact mass value is equals to given mass value 527.2339648000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
6-O-Carbamoylkanamycin A
A carbamoylkanamycin that is kanamycin A bearing a single carbamoyl substituent located at position 6 (on the 3-aminoglucose ring).
Hygromycin B
Hygromycin B is a fda approved antibiotic food additive for swine and poultry Hygromycin B is an antibiotic produced by the bacterium Streptomyces hygroscopicus. It is an aminoglycoside that kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis. In the laboratory it is used for the selection and maintenance of prokaryotic and eukaryotic cells that contain the hygromycin resistance gene. The resistance gene is a kinase that inactivates hygromycin B through phosphorylation. Since the discovery of hygromycin-resistance genes, hygromycin B has become a standard selection antibiotic in gene transfer experiments in many prokaryotic and eukaryotic cells D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents FDA approved antibiotic food additive for swine and poultry Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Rolitetracycline
C27H33N3O8 (527.2267538000001)
Rolitetracycline is only found in individuals that have used or taken this drug. It is a pyrrolidinylmethyl tetracycline.Rolitetracycline is a semisynthetic broad-spectrum tetracycline antibiotic used especially for parenteral administration in cases requiring high concentrations or when oral administration is impractical. Rolitetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Zosuquidar
(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
C27H33N3O8 (527.2267538000001)
Rolitetracycline
C27H33N3O8 (527.2267538000001)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines A derivative of tetracycline in which the amide function is substituted with a pyrrolidinomethyl group. C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Ala Phe Gln Tyr
Ala Phe Tyr Gln
Ala Gln Phe Tyr
Ala Gln Tyr Phe
Ala Tyr Phe Gln
Ala Tyr Gln Phe
Asp Glu His Lys
C21H33N7O9 (527.2339648000001)
Asp Glu Lys His
C21H33N7O9 (527.2339648000001)
Asp His Glu Lys
C21H33N7O9 (527.2339648000001)
Asp His Lys Glu
C21H33N7O9 (527.2339648000001)
Asp Lys Glu His
C21H33N7O9 (527.2339648000001)
Asp Lys His Glu
C21H33N7O9 (527.2339648000001)
Glu Asp His Lys
C21H33N7O9 (527.2339648000001)
Glu Asp Lys His
C21H33N7O9 (527.2339648000001)
Glu His Asp Lys
C21H33N7O9 (527.2339648000001)
Glu His Lys Asp
C21H33N7O9 (527.2339648000001)
Glu Lys Asp His
C21H33N7O9 (527.2339648000001)
Glu Lys His Asp
C21H33N7O9 (527.2339648000001)
Glu Pro Pro Trp
Glu Pro Trp Pro
Glu Trp Pro Pro
Phe Ala Gln Tyr
Phe Ala Tyr Gln
Phe Phe Asn Thr
Phe Phe Gln Ser
Phe Phe Ser Gln
Phe Phe Thr Asn
Phe Asn Phe Thr
Phe Asn Thr Phe
Phe Gln Ala Tyr
Phe Gln Phe Ser
Phe Gln Ser Phe
Phe Gln Tyr Ala
Phe Ser Phe Gln
Phe Ser Gln Phe
Phe Thr Phe Asn
Phe Thr Asn Phe
Phe Tyr Ala Gln
Phe Tyr Gln Ala
His Asp Glu Lys
C21H33N7O9 (527.2339648000001)
His Asp Lys Glu
C21H33N7O9 (527.2339648000001)
His Glu Asp Lys
C21H33N7O9 (527.2339648000001)
His Glu Lys Asp
C21H33N7O9 (527.2339648000001)
His Lys Asp Glu
C21H33N7O9 (527.2339648000001)
His Lys Glu Asp
C21H33N7O9 (527.2339648000001)
Lys Asp Glu His
C21H33N7O9 (527.2339648000001)
Lys Asp His Glu
C21H33N7O9 (527.2339648000001)
Lys Glu Asp His
C21H33N7O9 (527.2339648000001)
Lys Glu His Asp
C21H33N7O9 (527.2339648000001)
Lys His Asp Glu
C21H33N7O9 (527.2339648000001)
Lys His Glu Asp
C21H33N7O9 (527.2339648000001)
Lys Met Ser Tyr
Lys Met Tyr Ser
Lys Ser Met Tyr
Lys Ser Tyr Met
Lys Tyr Met Ser
Lys Tyr Ser Met
Met Lys Ser Tyr
Met Lys Tyr Ser
Met Ser Lys Tyr
Met Ser Tyr Lys
Met Tyr Lys Ser
Met Tyr Ser Lys
Asn Phe Phe Thr
Asn Phe Thr Phe
Asn Thr Phe Phe
Pro Glu Pro Trp
Pro Glu Trp Pro
Pro Pro Glu Trp
Pro Pro Trp Glu
Pro Trp Glu Pro
Pro Trp Pro Glu
Gln Ala Phe Tyr
Gln Ala Tyr Phe
Gln Phe Ala Tyr
Gln Phe Phe Ser
Gln Phe Ser Phe
Gln Phe Tyr Ala
Gln Ser Phe Phe
Gln Tyr Ala Phe
Gln Tyr Phe Ala
Ser Phe Phe Gln
Ser Phe Gln Phe
Ser Lys Met Tyr
Ser Lys Tyr Met
Ser Met Lys Tyr
Ser Met Tyr Lys
Ser Gln Phe Phe
Ser Tyr Lys Met
Ser Tyr Met Lys
Thr Phe Phe Asn
Thr Phe Asn Phe
Thr Asn Phe Phe
Trp Glu Pro Pro
Trp Pro Glu Pro
Trp Pro Pro Glu
Tyr Ala Phe Gln
Tyr Ala Gln Phe
Tyr Phe Ala Gln
Tyr Phe Gln Ala
Tyr Lys Met Ser
Tyr Lys Ser Met
Tyr Met Lys Ser
Tyr Met Ser Lys
Tyr Gln Ala Phe
Tyr Gln Phe Ala
Tyr Ser Lys Met
Tyr Ser Met Lys
Zosuquidar
C1744 - Multidrug Resistance Modulator
SBC-115076
SBC-115076 is a potent proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. PCSK9 is a proprotein convertase, which plays a crucial role in LDL receptor metabolism[1][2].
(E)-1-(5-((E)-(3-Fluorodibenzo(b,E)oxepin-11(6H)-ylidene)methyl)-1-((R)-1-morpholinopropan-2-yl)-1H-benzo(d)imidazol-2(3H)-ylidene)urea
[(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-hydroxy-5-methyl-4-(methylamino)oxan-3-yl] dihydrogen phosphate
(3aS,4S,4R,5S,6R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6-[(1R)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2-oxane]-3,4,5,7-tetrol
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-pentyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2,3-dihydroxy-2-pentyl-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
Antihelmycin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Destomysin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
1-(3-hydroperoxy-3-methylbut-1-en-1-yl)-3',4'-dihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2,2',8'-trione
C27H33N3O8 (527.2267538000001)
(2r,3'r,3as,4s,4's,5'r,6r,6'r,7s,7as)-4-{[(1s,2r,3s,5r,6s)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy}-6'-[(1r)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
(3'r,4s,4'r,5'r,6r,7s)-4-{[(1r,2s,3r,5s,6r)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy}-6'-[(1s)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
(9r,13r,14r,17s,23r,24s)-13,23,24-trihydroxy-5-methoxy-12,12-dimethyl-9-(2-methylprop-1-en-1-yl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraene-16,22-dione
C27H33N3O8 (527.2267538000001)
23,24-dihydroxy-9-(3-hydroxy-2-methylprop-1-en-1-yl)-5-methoxy-12,12-dimethyl-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraene-16,22-dione
C27H33N3O8 (527.2267538000001)
(9r,14s,17s,23r,24s)-23,24-dihydroxy-9-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]-5-methoxy-12,12-dimethyl-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraene-16,22-dione
C27H33N3O8 (527.2267538000001)
(3s,3'r,4's,6's,9's)-1-[(1e)-3-hydroperoxy-3-methylbut-1-en-1-yl]-3',4'-dihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2,2',8'-trione
C27H33N3O8 (527.2267538000001)
13,23,24-trihydroxy-5-methoxy-12,12-dimethyl-9-(2-methylprop-1-en-1-yl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraene-16,22-dione
C27H33N3O8 (527.2267538000001)